Subconjunctival Atropine and Intracameral Epinephrine for Pupil Dilation in Phacoemulsification

Clinical trial NCT03638726 · UNKNOWN

Trial details

NCT number: NCT03638726
Sponsor: Dar El Oyoun Hospital
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Cataract Mydriasis Adverse Drug Event

Start date: 2018-09-28
Primary completion: 2019-03-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.